Optain Platform (Resolve + Optain Grading)
Overview
The Optain Platform represents a significant advancement in preventative eye care, offering physicians a powerful, AI-driven solution for the early detection of sight-threatening diseases. This innovative platform integrates the FDA-cleared Resolve robotic camera with sophisticated AI-powered grading algorithms. Its primary objective is to enable the timely identification of diabetic retinopathy (DR), suspect glaucoma, and age-related macular degeneration (AMD) directly within primary care, endocrinology, and other non-ophthalmic clinical settings.
At its core, the Optain Platform utilizes a fully automated, non-mydriatic retinal imaging process, eliminating the need for pupil dilation and making the screening process quick and comfortable for patients. The Resolve camera captures high-quality retinal images, which are then immediately analyzed by Optain’s proprietary AI. This artificial intelligence provides rapid, actionable results, empowering physicians to make informed decisions about patient care and appropriate referrals to ophthalmologists.
For physicians, the Optain Platform offers substantial benefits. It seamlessly integrates into existing clinical workflows, requiring minimal staff training and operational disruption. By bringing advanced eye screening to the point of care, it helps overcome barriers to access for many patients, particularly those in underserved areas or those who might otherwise miss crucial screenings. This not only enhances patient outcomes through earlier intervention but also positions practices to offer a valuable new service, potentially improving patient satisfaction and practice revenue.
The ability to screen for common and serious eye conditions like DR, glaucoma, and AMD within a general practice setting is transformative. It supports a proactive approach to patient health, allowing for the identification of conditions before they lead to irreversible vision loss. The Optain Platform is designed to be a critical tool in population health initiatives, ensuring more patients receive the preventative eye care they need to maintain their vision and overall well-being.
Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Key Features
- FDA-cleared robotic retinal camera (Resolve)
- AI-powered grading for diabetic retinopathy, suspect glaucoma, and AMD
- Non-mydriatic imaging (no pupil dilation required)
- Automated image capture
- Immediate, actionable results
- Designed for point-of-care screening
- Seamless workflow integration
- Secure cloud platform
Use Cases
- Diabetic retinopathy screening in primary care
- Suspect glaucoma identification in general practice
- Age-related macular degeneration detection
- Routine eye health screening in non-ophthalmic clinics
- Improving access to preventative eye care
- Population health screening for eye diseases
What Physicians Need to Know
Leverage Optain's seamless EHR integration to incorporate retinal screenings as a routine part of patient visits, especially for those with diabetes or at risk for cardiovascular disease. Utilize the multi-condition insights to broaden your diagnostic considerations beyond primary eye conditions. Remember that while the AI provides rapid, accurate assessments, the final interpretation and patient management remain under the physician's purview, supported by the detailed reports and the auditing process.
Optain offers seamless integration with major Electronic Health Record (EHR) systems, facilitating order placement, wireless image upload, and the direct flow of ICD-10-coded reports and discrete data into patient charts and quality dashboards. This minimizes data re-entry and streamlines the clinical workflow, making it a 'plug and play' solution with most fundus cameras.
Details
| Category | Clinical Decision Support & Reference, Ophthalmology AI, Radiology & Imaging AI |
| Pricing | Contact for pricing — unknown |
| Deployment | Cloud-connected, on-premise (desktop/server for software) |
| Mobile App | No |
| API Available | Unknown |
| Data Export | Unknown |
| Languages | Multiple (at least 9 for patient UI) |
| Training | Unknown |
| Target Size | Small to large health systems, primary care, community programs |
| Compliance | |
| BAA Available | Yes AI-estimated |
| HIPAA Compliant | Yes AI-estimated |
| FDA Status |
Yes AI-estimated Resolve™ Fundus Camera (K250683) is FDA-cleared for taking digital images of a human retina with or without the use of a mydriatic agent, intended as an aid to clinicians in the evaluation and diagnosis of ocular health. |
| Integrations | |
| EHR | Not specified |
| Specialties | Endocrinology, Family Medicine, Internal Medicine, Ophthalmology, Optometry |
Social Proof
| Customers | 200 provider sites globally, with over 1,000 deployments in planning |
Support & Reliability
| Training Provided | Unknown |
What the Web Says
Optain Platform, comprising Resolve and Optain Grading, is a healthcare technology solution designed to enhance the analysis and grading of medical images, particularly in ophthalmology. It aims to improve efficiency and accuracy for physicians by automating certain aspects of image assessment and providing structured data.
Overall: MixedStrengths
- Improved efficiency in image analysis and grading workflows.
- Enhanced accuracy through automated or semi-automated grading features.
- Standardization of image assessment across different users.
- Potential for better patient outcomes due to more consistent evaluations.
- User-friendly interface reported by some users.
- Integration capabilities with existing healthcare IT systems.
Limitations
- Steep learning curve for new users.
- Initial setup and integration can be complex and time-consuming.
- Cost of implementation and ongoing subscriptions may be high for smaller practices.
- Reliance on internet connectivity for cloud-based features.
- Potential for over-reliance on automation, reducing critical human oversight.
- Limited specific reviews from physicians or healthcare IT professionals publicly available on major review sites like G2 or Capterra.
Based on reviews from: Optain.com (product information), Healthcare IT news articles (general industry trends), Medical technology publications (general industry trends), Reddit (general discussions on healthcare tech, limited specific mentions), LinkedIn (professional discussions, limited specific reviews)
Last updated: 2026-08-07
Ratings & Reviews
No reviews yet. Be the first to review this tool!
Rate Optain Platform (Resolve + Optain Grading)
Press & Coverage
Videos
Product demos, reviews, and walkthroughs for Optain Platform (Resolve + Optain Grading).
How to get ANY book for FREE (Donu2019t tell Amazon) #shorts
EasyA
How to get 9 hp in cuphead
TheJester
u3010u66f4u65b0u7b2c7u5b63u3011u4e00u53e3u6c14u770bu5b8c1-7u5b63ud83dudd25u86eeu8352u65e0u7075u6839u7684u5c11u5e74u6ca6u4e3au5b97u95e8u6700u4f4eu8d31u7684u6742u5f79uff0cu610fu5916u5076u9047u4e00u67c4u6b8bu7834u4ed9u5251uff01u770bu4ed6u5982u4f55u5f00u542fu964du7ef4u5916u6302 | MULTI SUB
Amazing Anime Man
How to get a girls number ud83dude0f @rachelmichellepizzolato #shorts #magic #challenge
BradSmit
Get Up From Floor Seniors
Total Therapy Solution - Physical Therapy
Bone on bone knee pain- how to find relief with no cartilage
Alyssa Kuhn, Arthritis Adventure
Frequently Asked Questions
Compare Optain Platform (Resolve + Optain Grading)
Investors who backed Optain Platform (Resolve + Optain Grading)
Funded through the company that built this tool.
